Nisa Investment Advisors, LLC G1 Therapeutics, Inc. Transaction History

Nisa Investment Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$4.04 - $8.51 $5,656 - $11,914	-1,400 Reduced 67.37%	678 $3,000
Q1 2022 Apr 29, 2022	BUY	$7.6 - $11.02 $10,640 - $15,428	1,400 Added 206.49%	2,078 $16,000
Q4 2021 Feb 03, 2022	SELL	$10.16 - $16.17 $7,112 - $11,319	-700 Reduced 50.8%	678 $7,000
Q4 2020 Jan 25, 2021	BUY	$10.99 - $20.4 $10,440 - $19,380	950 Added 221.96%	1,378 $25,000
Q1 2020 Apr 17, 2020	BUY	$9.07 - $26.32 $1,451 - $4,211	160 Added 59.7%	428 $5,000
Q4 2019 Jan 17, 2020	SELL	$20.54 - $31.0 $513,500 - $775,000	-25,000 Reduced 98.94%	268 $7,000
Q3 2019 Oct 17, 2019	BUY	$22.78 - $40.58 $564,215 - $1.01 Million	24,768 Added 4953.6%	25,268 $576,000
Q2 2019 Jul 12, 2019	BUY	$16.03 - $31.1 $5,610 - $10,885	350 Added 233.33%	500 $15,000
Q3 2018 Oct 16, 2018	BUY	$43.15 - $67.97 $6,472 - $10,195	150 New	150 $8,000

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Nisa Investment Advisors, LLC with notifications on news.